The challenge of early synovitis: Multiple pathways to a common clinical syndrome

Arthritis Research

Volumn 1, Issue 1, 1999, Pages 31-36

  El Gabalawy, H ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BACTERIAL ANTIGEN; BACTERIAL DNA; BACTERIAL RNA; HLA B27 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY DETECTION; BONE EROSION; BORRELIA BURGDORFERI; CELL INFILTRATION; CHLAMYDIA TRACHOMATIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; HUMAN; JOINT RADIOGRAPHY; LYME DISEASE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CELL; POLYARTHRITIS; PROGNOSIS; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SYNOVITIS;

AGE OF ONSET; ANIMALS; ARTHRITIS, INFECTIOUS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; HUMANS; PROGNOSIS; SYNOVITIS;

EID: 0033281712     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar8     Document Type: Review

References (66)

1. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
2. The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy
3. Association of HLA alleles and clinical features in patients with synovitis of recent onset
4. Undifferentiated arthritis in an early synovitis out-patient clinic
5. Inflammatory polyarthritis in the community is not a benign disease: Predicting functional disability one year after presentation
6. The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: A study of 1141 patients
7. Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic
8. Undifferentiated arthritis and reactive arthritis
9. Magnetic resonance imaging in the assessment of rheumatoid arthritis: A comparison with plain film radiographs
10. Detection of joint pathology by magnetic resonance imaging in patients with early rheumatoid arthritis
11. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset
12. Sensitivity of magnetic resonance imaging of the wrist in very early rheumatoid arthritis
13. Contrast enhanced Gd-DTPA magnetic resonance imaging in the evaluation of rheumatoid arthritis during a clinical trial with DMARDs. A prospective two-year follow-up study on hand joints in 31 patients
14. Advantages of an increased dose of MRI contrast agent for enhancing inflammatory synovium
15. Magnetic resonance imaging-determined synovial membrane and joint effusion volumes in rheumatoid arthritis and osteoarthritis: Comparison with the macroscopic and microscopic appearance of the synovium
16. Quantification of synovistis by MRI: Correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation
17. Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis
18. Prognostic value of contrast enhanced Gd-DTPA MRI for development of bone erosive changes in rheumatoid arthritis
19. Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging
20. Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy
21. Classification of inflammatory arthritis by enthesitis
22. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity
23. p53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis
24. Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia induced arthritis and osteoarthritis
25. Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis
26. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis
27. Pathogenesis of joint damage in rheumatoid arthritis
28. Asymptomatic synovitis precedes clinically manifest arthritis
29. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis
30. Ultrastructural demonstration of spirochetal antigens in synovial fluid and synovial membrane in chronic Lyme disease: Possible factors contributing to persistence of organisms
31. Detection of Borrelia burgdorferi sensu stricto by reverse line blot in the joints of Dutch patients with lyme arthritis
32. Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy
33. Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with lyme arthritis
34. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis
35. Spirochetal antigens and lymphoid-cell surface markers in Lyme synovitis: Comparison with rheumatoid synovium and tonsillar lymphoid tissue
36. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis
37. Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects
38. Does the presence of C-trachomatis in synovial tissue correlate with immune serology and outcome in recent onset synovitis?
39. In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis
40. Divergent T-cell cytokine patterns in inflammatory arthritis
41. Gamma interferon and interleukin-10 gene expression in synovial tissues from patients with early stages of Chlamydia associated arthritis and undifferentiated oligoarthritis and from healthy volunteers
42. In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis
43. Synovial Chlamydia trachomatis in patients with reactive arthritis Reiter's syndrome are viable but show aberrant gene expression
44. Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome
45. Human parvovirus B19 as a causative agent for rheumatoid arthritis
46. Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope
47. Rheumatoid arthritis associated autoimmune systems
48. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies
49. The Sa system: A novel antigen-antibody system specific for rheumatoid arthritis
50. Detection and expression of a cDNA clone that encodes a polypeptide containing 2 inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera
51. A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE
52. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus mixed connective tissue disease
53. The mechanism of autoantibody formation to cartilage in rheumatoid arthritis: Possible cross-reaction of antibodies to dietary collagens with autologous type II collagen
54. RA associated autoantibodies define subsets of patients with early synovitis
55. The shared epitope hypothesis: An approach to understanding the molecular-genetics of susceptibility to rheumatoid arthritis
56. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis
57. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: A novel model for human polyarthritis
58. Could HLA-DRB1 be the protective locus in rheumatoid arthritis?
59. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis
60. No support for HLA-DQ encoded susceptibility in rheumatoid arthritis
61. B27-bearing HLA haplotypes in rheumatoid arthritis: Characterization in Finnish patients
62. The prognostic value of HLA-DR4 and HLA-B27 antigens in early rheumatoid arthritis
63. Identification of genes controlling collagen-induced arthritis in mice: Striking homology with susceptibility loci previously identified in the rat
64. Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats
65. The detection of DNA from a range of bacterial species in the joints of patients with a variety of arthritides using a nested, broad-range polymerase chain reaction
66. Detection of bacterial DNA in joint samples from patients with undifferentiated arthritis and reactive arthritis, using polymerase chain reaction with universal 16S ribosomal RNA primers